Who Owns Medicinova Stock?
NASDAQ: MNOVHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 20.38%
- Held by insiders
- 2.86%
- Institutional holders
- 38
- Institutions 20.4%
- Insiders 2.9%
- Public and other 76.8%
Who owns Medicinova stock?
Institutional investors own about 20.4% of Medicinova's shares, spread across 38 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 2.86% of MNOV.
The largest institutional holders are Essex Woodlands Management Inc. (2.25%), Blackrock Inc. (1.53%) and Citigroup Inc. (1.29%). Together, the top 10 institutions control 9.5% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their MNOV positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of MNOV
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Essex Woodlands Management Inc. | 1.11M | 2.25% | 0.0% |
| Blackrock Inc. | 752.09K | 1.53% | +6.5% |
| Citigroup Inc. | 635.72K | 1.29% | 0.0% |
| Vanguard Capital Management LLC | 609.05K | 1.24% | -0.3% |
| Geode Capital Management, LLC | 539.31K | 1.10% | -0.8% |
| Vanguard Fiduciary Trust Co | 282.61K | 0.57% | +0.7% |
| UBS Group AG | 222.20K | 0.45% | 0.0% |
| Renaissance Technologies, LLC | 205.40K | 0.42% | +8.2% |
| State Street Corporation | 193.70K | 0.39% | 0.0% |
| Northern Trust Corporation | 143.66K | 0.29% | +7.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of MNOV
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 609.05K | 1.24% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 251.21K | 0.51% |
| iShares Trust-iShares Micro-Cap ETF | 157.93K | 0.32% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 87.58K | 0.18% |
| SCHWAB CAPITAL TRUST-Schwab Total Stock Market Index Fund | 71.51K | 0.15% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 68.41K | 0.14% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 24.53K | 0.05% |
| Northern Funds-SMALL CAP CORE FUND | 13.89K | 0.03% |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 10.53K | 0.02% |
| LINCOLN Varbl INSURANCE Prod. TRT-LVIP Dimensional U.S. Core Eqy. 2 Fd | 6.69K | 0.01% |
Frequently asked questions
Who is the largest shareholder of Medicinova?
Essex Woodlands Management Inc. is the largest institutional shareholder of MNOV, owning 2.25% of shares outstanding (1.11M shares) as of its latest 13F filing.
What percentage of Medicinova is owned by institutions?
Institutions own about 20.4% of MNOV shares and 21.0% of the public float.
How much of Medicinova do insiders own?
Insiders, such as officers and directors, own about 2.86% of MNOV shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.